Russell T. Matthews, Ph.D. - Publications

Affiliations: 
2001 Yale University, New Haven, CT 

70 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Blosa M, Bursch C, Weigel S, Holzer M, Jäger C, Janke C, Matthews RT, Arendt T, Morawski M. Reorganization of Synaptic Connections and Perineuronal Nets in the Deep Cerebellar Nuclei of Purkinje Cell Degeneration Mutant Mice. Neural Plasticity. 2016: 2828536. PMID 26819763 DOI: 10.1155/2016/2828536  0.84
2015 Dwyer CA, Katoh T, Tiemeyer M, Matthews RT. Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain. The Journal of Biological Chemistry. 290: 10256-73. PMID 25737452 DOI: 10.1074/jbc.M114.614099  0.84
2014 Dwyer CA, Bi WL, Viapiano MS, Matthews RT. Brevican knockdown reduces late-stage glioma tumor aggressiveness. Journal of Neuro-Oncology. 120: 63-72. PMID 25052349 DOI: 10.1007/s11060-014-1541-z  0.84
2013 Jäger C, Lendvai D, Seeger G, Brückner G, Matthews RT, Arendt T, Alpár A, Morawski M. Perineuronal and perisynaptic extracellular matrix in the human spinal cord. Neuroscience. 238: 168-84. PMID 23428622 DOI: 10.1016/j.neuroscience.2013.02.014  0.84
2013 Blosa M, Sonntag M, Brückner G, Jäger C, Seeger G, Matthews RT, Rübsamen R, Arendt T, Morawski M. Unique features of extracellular matrix in the mouse medial nucleus of trapezoid body--implications for physiological functions. Neuroscience. 228: 215-34. PMID 23069754 DOI: 10.1016/j.neuroscience.2012.10.003  0.84
2013 Kind PC, Sengpiel F, Beaver CJ, Crocker-Buque A, Kelly GM, Matthews RT, Mitchell DE. The development and activity-dependent expression of aggrecan in the cat visual cortex. Cerebral Cortex (New York, N.Y. : 1991). 23: 349-60. PMID 22368089 DOI: 10.1093/cercor/bhs015  0.84
2012 Dwyer CA, Baker E, Hu H, Matthews RT. RPTPζ/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1. Neuroscience. 220: 47-61. PMID 22728091 DOI: 10.1016/j.neuroscience.2012.06.026  0.84
2012 Lee JK, Matthews RT, Lim JM, Swanier K, Wells L, Pierce JM. Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V. The Journal of Biological Chemistry. 287: 28526-36. PMID 22715095 DOI: 10.1074/jbc.M112.367565  0.84
2012 Giamanco KA, Matthews RT. Deconstructing the perineuronal net: cellular contributions and molecular composition of the neuronal extracellular matrix. Neuroscience. 218: 367-84. PMID 22659016 DOI: 10.1016/j.neuroscience.2012.05.055  0.84
2012 Morawski M, Brückner G, Arendt T, Matthews RT. Aggrecan: Beyond cartilage and into the brain. The International Journal of Biochemistry & Cell Biology. 44: 690-3. PMID 22297263 DOI: 10.1016/j.biocel.2012.01.010  0.84
2012 Morawski M, Brückner G, Jäger C, Seeger G, Matthews RT, Arendt T. Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology. Brain Pathology (Zurich, Switzerland). 22: 547-61. PMID 22126211 DOI: 10.1111/j.1750-3639.2011.00557.x  0.84
2012 Lendvai D, Morawski M, Brückner G, Négyessy L, Baksa G, Glasz T, Patonay L, Matthews RT, Arendt T, Alpár A. Perisynaptic aggrecan-based extracellular matrix coats in the human lateral geniculate body devoid of perineuronal nets. Journal of Neuroscience Research. 90: 376-87. PMID 21959900 DOI: 10.1002/jnr.22761  0.84
2011 Kähler AK, Djurovic S, Rimol LM, Brown AA, Athanasiu L, Jönsson EG, Hansen T, Gústafsson O, Hall H, Giegling I, Muglia P, Cichon S, Rietschel M, Pietiläinen OP, Peltonen L, ... ... Matthews RT, et al. Candidate gene analysis of the human natural killer-1 carbohydrate pathway and perineuronal nets in schizophrenia: B3GAT2 is associated with disease risk and cortical surface area. Biological Psychiatry. 69: 90-6. PMID 20950796 DOI: 10.1016/j.biopsych.2010.07.035  0.84
2010 Matsuki T, Matthews RT, Cooper JA, van der Brug MP, Cookson MR, Hardy JA, Olson EC, Howell BW. Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment. Cell. 143: 826-36. PMID 21111240 DOI: 10.1016/j.cell.2010.10.029  0.84
2010 Giamanco KA, Morawski M, Matthews RT. Perineuronal net formation and structure in aggrecan knockout mice. Neuroscience. 170: 1314-27. PMID 20732394 DOI: 10.1016/j.neuroscience.2010.08.032  0.84
2010 Gáti G, Morawski M, Lendvai D, Matthews RT, Jäger C, Zachar G, Arendt T, Alpár A. Chondroitin sulphate proteoglycan-based perineuronal net establishment is largely activity-independent in chick visual system. Journal of Chemical Neuroanatomy. 40: 243-7. PMID 20621181 DOI: 10.1016/j.jchemneu.2010.07.002  0.84
2010 Rostomily RC, Born DE, Beyer RP, Jin J, Alvord EC, Mikheev AM, Matthews RT, Pan C, Khorasani L, Sonnen JA, Montine TJ, Shi M, Zhang J. Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion. Journal of Proteome Research. 9: 2610-8. PMID 20337498 DOI: 10.1021/pr100054v  0.84
2008 Abbott KL, Matthews RT, Pierce M. Receptor tyrosine phosphatase beta (RPTPbeta) activity and signaling are attenuated by glycosylation and subsequent cell surface galectin-1 binding. The Journal of Biological Chemistry. 283: 33026-35. PMID 18838383 DOI: 10.1074/jbc.M803646200  0.84
2008 Hu B, Kong LL, Matthews RT, Viapiano MS. The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility. The Journal of Biological Chemistry. 283: 24848-59. PMID 18611854 DOI: 10.1074/jbc.M801433200  0.84
2008 Viapiano MS, Hockfield S, Matthews RT. BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion. Journal of Neuro-Oncology. 88: 261-72. PMID 18398576 DOI: 10.1007/s11060-008-9575-8  0.84
2008 Massey JM, Amps J, Viapiano MS, Matthews RT, Wagoner MR, Whitaker CM, Alilain W, Yonkof AL, Khalyfa A, Cooper NG, Silver J, Onifer SM. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Experimental Neurology. 209: 426-45. PMID 17540369 DOI: 10.1016/j.expneurol.2007.03.029  0.84
2007 McRae PA, Rocco MM, Kelly G, Brumberg JC, Matthews RT. Sensory deprivation alters aggrecan and perineuronal net expression in the mouse barrel cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 5405-13. PMID 17507562 DOI: 10.1523/JNEUROSCI.5425-06.2007  0.84
2006 Dino MR, Harroch S, Hockfield S, Matthews RT. Monoclonal antibody Cat-315 detects a glycoform of receptor protein tyrosine phosphatase beta/phosphacan early in CNS development that localizes to extrasynaptic sites prior to synapse formation. Neuroscience. 142: 1055-69. PMID 16989954 DOI: 10.1016/j.neuroscience.2006.07.054  0.84
2006 Viapiano MS, Matthews RT. From barriers to bridges: chondroitin sulfate proteoglycans in neuropathology. Trends in Molecular Medicine. 12: 488-96. PMID 16962376 DOI: 10.1016/j.molmed.2006.08.007  0.84
2005 Sloan KE, Stewart JK, Treloar AF, Matthews RT, Jay DG. CD155/PVR enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics. Cancer Research. 65: 10930-7. PMID 16322240 DOI: 10.1158/0008-5472.CAN-05-1890  0.84
2005 Viapiano MS, Bi WL, Piepmeier J, Hockfield S, Matthews RT. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas. Cancer Research. 65: 6726-33. PMID 16061654 DOI: 10.1158/0008-5472.CAN-05-0585  0.84
2005 Andrews ZB, Horvath B, Barnstable CJ, Elsworth J, Elseworth J, Yang L, Beal MF, Roth RH, Matthews RT, Horvath TL. Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 184-91. PMID 15634780 DOI: 10.1523/JNEUROSCI.4269-04.2005  0.84
2004 Kelsey JE, Mague SD, Pijanowski RS, Harris RC, Kleckner NW, Matthews RT. NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats. Psychopharmacology. 175: 179-88. PMID 15007533 DOI: 10.1007/s00213-004-1799-5  0.84
2003 Diano S, Matthews RT, Patrylo P, Yang L, Beal MF, Barnstable CJ, Horvath TL. Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology. 144: 5014-21. PMID 12960023 DOI: 10.1210/en.2003-0667  0.84
2003 Horvath TL, Diano S, Leranth C, Garcia-Segura LM, Cowley MA, Shanabrough M, Elsworth JD, Sotonyi P, Roth RH, Dietrich EH, Matthews RT, Barnstable CJ, Redmond DE. Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease. Endocrinology. 144: 2757-60. PMID 12810526 DOI: 10.1210/en.2003-0163  0.84
2003 Viapiano MS, Matthews RT, Hockfield S. A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma. The Journal of Biological Chemistry. 278: 33239-47. PMID 12799382 DOI: 10.1074/jbc.M303480200  0.84
2002 Yuan W, Matthews RT, Sandy JD, Gottschall PE. Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats. Neuroscience. 114: 1091-101. PMID 12379262 DOI: 10.1016/S0306-4522(02)00347-0  0.84
2002 Matthews RT, Kelly GM, Zerillo CA, Gray G, Tiemeyer M, Hockfield S. Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 7536-47. PMID 12196577  0.84
2001 Shefner JM, Brown RH, Cole D, Chaturvedi P, Schoenfeld D, Pastuszak K, Matthews R, Upton-Rice M, Cudkowicz ME. Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations. Neurology. 57: 1857-61. PMID 11723276  0.84
2001 Nutt CL, Matthews RT, Hockfield S. Glial tumor invasion: a role for the upregulation and cleavage of BEHAB/brevican. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 7: 113-22. PMID 11496922  0.84
2000 Matthews RT, Gary SC, Zerillo C, Pratta M, Solomon K, Arner EC, Hockfield S. Brain-enriched hyaluronan binding (BEHAB)/brevican cleavage in a glioma cell line is mediated by a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family member. The Journal of Biological Chemistry. 275: 22695-703. PMID 10801887 DOI: 10.1074/jbc.M909764199  0.84
2000 Kaddurah-Daouk R, Matthews R, Beal MF. Amyotrophic lateral sclerosis: Transgenic model and novel neuroprotective agent Neuroscience Research Communications. 26: 215-226. DOI: 10.1002/1520-6769(200005/06)26:3<215::AID-NRC9>3.0.CO;2-Z  0.84
1999 Matthews RT, Ferrante RJ, Klivenyi P, Yang L, Klein AM, Mueller G, Kaddurah-Daouk R, Beal MF. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Experimental Neurology. 157: 142-9. PMID 10222117 DOI: 10.1006/exnr.1999.7049  0.84
1999 Matthews RT, Klivenyi P, Mueller G, Yang L, Wermer M, Thomas CE, Beal MF. Novel free radical spin traps protect against malonate and MPTP neurotoxicity. Experimental Neurology. 157: 120-6. PMID 10222114 DOI: 10.1006/exnr.1999.7045  0.84
1999 Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, Beal MF. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Medicine. 5: 347-50. PMID 10086395 DOI: 10.1038/6568  0.84
1998 Schulz JB, Weller M, Matthews RT, Heneka MT, Groscurth P, Martinou JC, Lommatzsch J, von Coelln R, Wüllner U, Löschmann PA, Beal MF, Dichgans J, Klockgether T. Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia. Cell Death and Differentiation. 5: 847-57. PMID 10203688 DOI: 10.1038/sj.cdd.4400420  0.84
1998 Yang L, Matthews RT, Schulz JB, Klockgether T, Liao AW, Martinou JC, Penney JB, Hyman BT, Beal MF. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 8145-52. PMID 9763461  0.84
1998 Klivenyi P, Matthews RT, Wermer M, Yang L, MacGarvey U, Becker DA, Natero R, Beal MF. Azulenyl nitrone spin traps protect against MPTP neurotoxicity. Experimental Neurology. 152: 163-6. PMID 9682023 DOI: 10.1006/exnr.1998.6824  0.84
1998 Matthews RT, Yang L, Browne S, Baik M, Beal MF. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proceedings of the National Academy of Sciences of the United States of America. 95: 8892-7. PMID 9671775 DOI: 10.1073/pnas.95.15.8892  0.84
1998 Beal MF, Matthews RT, Tieleman A, Shults CW. Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Research. 783: 109-14. PMID 9479058 DOI: 10.1016/S0006-8993(97)01192-X  0.84
1998 Matthews RT, Yang L, Jenkins BG, Ferrante RJ, Rosen BR, Kaddurah-Daouk R, Beal MF. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 156-63. PMID 9412496  0.84
1997 Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Annals of Neurology. 42: 644-54. PMID 9382477 DOI: 10.1002/ana.410420416  0.84
1997 Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, Keltner JR, Beal MF, Rosen BR, Jenkins BG. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 38: 389-98. PMID 9339439 DOI: 10.1002/mrm.1910380306  0.84
1997 Matthews RT, Beal MF, Fallon J, Fedorchak K, Huang PL, Fishman MC, Hyman BT. MPP+ induced substantia nigra degeneration is attenuated in nNOS knockout mice. Neurobiology of Disease. 4: 114-21. PMID 9331901 DOI: 10.1006/nbdi.1997.0141  0.84
1997 Schulz JB, Matthews RT, Klockgether T, Dichgans J, Beal MF. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Molecular and Cellular Biochemistry. 174: 193-7. PMID 9309687 DOI: 10.1023/A:1006852306789  0.84
1997 Ferrante RJ, Shinobu LA, Schulz JB, Matthews RT, Thomas CE, Kowall NW, Gurney ME, Beal MF. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Annals of Neurology. 42: 326-34. PMID 9307254 DOI: 10.1002/ana.410420309  0.84
1997 Ayata C, Ayata G, Hara H, Matthews RT, Beal MF, Ferrante RJ, Endres M, Kim A, Christie RH, Waeber C, Huang PL, Hyman BT, Moskowitz MA. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 6908-17. PMID 9278526  0.84
1997 Beal MF, Matthews RT. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases. Molecular Aspects of Medicine. 18: S169-79. PMID 9266519 DOI: 10.1016/S0098-2997(97)00024-1  0.84
1997 Matthews RT, Ferrante RJ, Jenkins BG, Browne SE, Goetz K, Berger S, Chen IY, Beal MF. Iodoacetate produces striatal excitotoxic lesions. Journal of Neurochemistry. 69: 285-9. PMID 9202321  0.84
1997 Fallon J, Matthews RT, Hyman BT, Beal MF. MPP+ produces progressive neuronal degeneration which is mediated by oxidative stress. Experimental Neurology. 144: 193-8. PMID 9126170 DOI: 10.1006/exnr.1997.6416  0.84
1997 Matthews RT, Yang L, Beal MF. S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity. Experimental Neurology. 143: 282-6. PMID 9056390 DOI: 10.1006/exnr.1996.6406  0.84
1996 Galpern WR, Matthews RT, Beal MF, Isacson O. NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease. Neuroreport. 7: 2639-42. PMID 8981438  0.84
1996 Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Matthews RT, Beal MF. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nature Medicine. 2: 1017-21. PMID 8782460 DOI: 10.1038/nm0996-1017  0.84
1996 Matthews RT, Beal MF. Increased 3-nitrotyrosine in brains of Apo E-deficient mice. Brain Research. 718: 181-4. PMID 8773783 DOI: 10.1016/0006-8993(95)01576-0  0.84
1996 Kirschner PB, Jenkins BG, Schulz JB, Finkelstein SP, Matthews RT, Rosen BR, Beal MF. NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals. Brain Research. 713: 178-85. PMID 8724989 DOI: 10.1016/0006-8993(95)01513-2  0.84
1996 Schulz JB, Matthews RT, Henshaw DR, Beal MF. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases. Neuroscience. 71: 1043-8. PMID 8684608 DOI: 10.1016/0306-4522(95)00527-7  0.84
1996 Schulz JB, Huang PL, Matthews RT, Passov D, Fishman MC, Beal MF. Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. Journal of Neurochemistry. 67: 430-3. PMID 8667023  0.84
1995 Schulz JB, Matthews RT, Beal MF. Role of nitric oxide in neurodegenerative diseases. Current Opinion in Neurology. 8: 480-6. PMID 8845936  0.84
1995 Schulz JB, Matthews RT, Jenkins BG, Ferrante RJ, Siwek D, Henshaw DR, Cipolloni PB, Mecocci P, Kowall NW, Rosen BR. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 8419-29. PMID 8613773  0.84
1995 Schulz JB, Henshaw DR, Matthews RT, Beal MF. Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity. Experimental Neurology. 132: 279-83. PMID 7789466 DOI: 10.1016/0014-4886(95)90033-0  0.84
1995 Beal MF, Ferrante RJ, Henshaw R, Matthews RT, Chan PH, Kowall NW, Epstein CJ, Schulz JB. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. Journal of Neurochemistry. 65: 919-22. PMID 7616254  0.84
1995 Schulz JB, Matthews RT, Jenkins BG, Brar P, Beal MF. Improved therapeutic window for treatment of histotoxic hypoxia with a free radical spin trap. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 15: 948-52. PMID 7593355 DOI: 10.1038/jcbfm.1995.120  0.84
1995 Schulz JB, Matthews RT, Muqit MM, Browne SE, Beal MF. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. Journal of Neurochemistry. 64: 936-9. PMID 7530297  0.84
1994 Shults CW, Matthews RT, Altar CA, Hill LR, Langlais PJ. A single intramesencephalic injection of brain-derived neurotrophic factor induces persistent rotational asymmetry in rats. Experimental Neurology. 125: 183-94. PMID 8313937 DOI: 10.1006/exnr.1994.1023  0.84
1990 Kelsey JE, Aranow JS, Matthews RT. Context-specific morphine withdrawal in rats: duration and effects of clonidine. Behavioral Neuroscience. 104: 704-10. PMID 2244979 DOI: 10.1037//0735-7044.104.5.704  0.84
Show low-probability matches.